Workflow
OSS Appoints Lieutenant General David Bassett (Ret.) Board Member
GlobeNewswire· 2025-05-15 12:00
Lieutenant General David Bassett (Ret.) Bio Bassett currently serves as a Senior Counselor at The Cohen Group, a consulting firm based in Washington DC, where he advises on business development, regulatory affairs, and capital raising activities. Bassett's distinguished 35-year military career was marked by leadership in modernization efforts and the management of large-scale acquisition programs. From 2020-2023, Bassett served as Director of the Defense Contract Management Agency (DCMA), where he led more ...
Lifeward Ltd. Reports First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-15 12:00
Recent Highlights and Accomplishments for Lifeward U.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of resources and reduced expenditures yields improved operating expense trend Second consecutive quarter of AlterG revenue growth over 15% reflecting continued sales momentum MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company ...
Innovative Food Holdings, Inc. Reports Financial Results for First Quarter of 2025
GlobeNewswire· 2025-05-15 12:00
Key First Quarter data points: BROADVIEW, Ill., May 15, 2025 (GLOBE NEWSWIRE) -- Innovative Food Holdings, Inc. (OTCQB: IVFH) ("IVFH" or the "Company"), a national seller of gourmet specialty foods to professional chefs, today reported its financial results for the first quarter of 2025. Bill Bennett, Chief Executive Officer of IVFH, remarked, "The first quarter of 2025 marked additional progress against our strategic plan as we continued the second phase of our growth strategy (building the foundation for ...
Allegro MicroSystems to Present at TD Cowen’s 53rd Annual Technology, Media & Telecom Conference on Thursday, May 29, 2025
GlobeNewswire· 2025-05-15 12:00
MANCHESTER, N.H., May 15, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced that the company will present at TD Cowen’s 53rd Annual Technology, Media & Telecom Conference on Thursday, May 29, 2025 at the InterContinental New York Barclay in New York, NY. Derek D’Antilio, EVP and Chief Financial Officer, is scheduled to participate in a fireside chat at 1 ...
Intchains Group Limited to Participate in the “Virtual Digital Assets Seminar” Presented by Benchmark Company on Tuesday, May 20th at 9:45 a.m. EDT
GlobeNewswire· 2025-05-15 11:51
SINGAPORE, May 15, 2025 (GLOBE NEWSWIRE) -- Intchains Group Limited (Nasdaq: ICG) (“we,” or the “Company”), a company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies, and the active development of innovative Web3 applications, today announced it will be attending The Benchmark Company’s first iteration of their Virtual Digital Assets Seminar on Tuesday, May 20th EDT. The event features virtual Fireside Chats with dynamic pub ...
Ekso Bionics Accepted into NVIDIA Connect Program
GlobeNewswire· 2025-05-15 11:45
Company unveils a strategic initiative to build the world’s first known foundation model for human motion in physical rehabilitation Collaboration represents an important step toward integrating powerful new AI capabilities into Ekso Bionics’ proprietary exoskeleton technology platforms SAN RAFAEL, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced ...
Cerro de Pasco Resources to Pursue Secondary Listing on the Lima Stock Exchange
GlobeNewswire· 2025-05-15 11:45
MONTRÉAL, May 15, 2025 (GLOBE NEWSWIRE) -- Cerro de Pasco Resources Inc. (TSXV: CDPR) (OTCMKTS: GPPRF) (FRA: N8HP) (“CDPR” or the “Company”) is pleased to announce that it will pursue a secondary listing of its shares on the Lima Stock Exchange (Bolsa de Valores de Lima, “BVL”) as part of its strategy to expand its presence in Latin America and increase visibility among regional investors. The Company’s primary listing will remain on the TSX Venture Exchange (TSXV). The Company has retained Kallpa Securitie ...
N2OFF Energy Targets European's Energy Crises with Fourth Regional Battery Project
GlobeNewswire News Room· 2025-05-15 11:32
N2OFF to take part in financing a 35MW/140MWh planned Battery Energy Storage System project in Poland Neve Yarak, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech, recently announced its entry into the Polish renewable energy market by participating in the financing of a Battery Energy Storage System (BESS) project in Poland. The project, currently planned a ...
PyroGenesis Confirms Successful Collection of Material from Fumed Silica Pilot Plant Baghouse
GlobeNewswire· 2025-05-15 11:30
Material sent to 3rd party lab for analysisMONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes all-electric plasma processes and sustainable solutions to support heavy industry in their energy transition, emission reduction, commodity security, and waste remediation efforts, announces today that further to its news release dated May 13, 2025, and ...
Palvella Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire· 2025-05-15 11:30
Phase 3 SELVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of microcystic lymphatic malformations (microcystic LMs) has exceeded enrollment target of 40 patients; enrollment expected to close in June 2025 Phase 3 SELVA trial top-line results anticipated in the first quarter of 2026 Phase 2 TOIVA trial evaluating QTORIN™ rapamycin for the treatment of cutaneous venous malformations top-line results on track for the fourth quarter of 2025 QTORIN™ rapamycin has th ...